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Introduction
The importance of thyroid hormone transfer from the
mother to the fetus during the second half of human
pregnancy has received increasing acceptance (1). There
is also increasing awareness of the importance of mater-
nal thyroxine for the development of the brain early in
pregnancy — that is, before onset at midgestation of its
significant secretion by the fetal thyroid, a period dur-
ing which the mother is the only source of thyroid hor-
mone for the fetus. The experimental evidence and epi-
demiological findings have recently been reviewed (2–4).
Although much of the evidence from human studies is
related to maternal hypothyroxinemia caused by iodine
deficiency (ID), this conclusion has been extended to
pregnant women in the Netherlands (5) and the United
States (6, 7). Even in the Western populations, children
with some degree of neurodevelopmental impairment
caused by early maternal hypothyroxinemia may be
150–200 times more common than those with congen-
ital hypothyroidism (CH) (2).
The World Health Organization declared that ID is,
after starvation, the single most important cause of pre-
ventable brain damage, including different degrees of
mental retardation and disabling cerebral palsy. The
severity and potential irreversibility of the brain damage
are not only related to the degree of ID but also to the
period in life during which the individual was exposed
to it (8, 9). The most marked CNS damage is that of
some people with neurological cretinism, who are born
in areas of severe ID. The neurological abnormalities
include, among others, hearing and speech defects,
mental deficiency, and motor defects (10, 11), which are
clearly related to the mother’s ID and her consequent
inability to increase circulating thyroxine during preg-
nancy (9, 12–15). Moreover, it has more recently become
evident that maternal hypothyroxinemia not only
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results in the birth of children with neurological cre-
tinism but also in decreased mental and psychomotor
development of the rest of the population without cre-
tinism (16–19). People with neurological cretinism are
only born in areas of very severe ID, but the mental
development of the population as a whole is also affect-
ed by mild and moderate maternal ID (19, 20). The pre-
vention of both the marked CNS damage seen in the
people with neurological cretinism and of the mental
retardation of the population requires correction of the
maternal hypothyroxinemia before midgestation (16,
19–22) or the end of the second trimester (23), before
onset of significant fetal thyroid function. Third
trimester or early postnatal correction of the low circu-
lating T4, a measure that is quite effective in preventing
most CNS damage in CH, does not reverse the deficits
caused by maternal hypothyroxinemia because most of
the consequences have become permanent by the end of
the second trimester.
The term “hypothyroxinemia” is used here and else-
where (2, 3) to indicate that, whether or not clinical or
subclinical (with thyroid-stimulating hormone [TSH]
above normal values) hypothyroidism is present, T4 or
free T4 (FT4) is low as compared with values usually
found at the same stage of pregnancy in normal women
with adequate iodine intake. In the present context, it is
important to realize that iodine-deficient women are
hypothyroxinemic, but they are not clinically hypothy-
roid (9, 12), because their circulating 3,5,3′-triiodothy-
ronine (T3) is normal or even slightly elevated and suf-
ficient for euthyroidism of most tissues and organs.
TSH rarely increases above normal in these women (24,
25). Indeed, the severity of the CNS damage and mental
retardation of their progeny is causally correlated with
the degree of the maternal hypothyroxinemia and not
to changes in T3 or TSH (17, 22). In the study by Pop et
al. (5) performed in the Netherlands, a country consid-
ered to be free of ID, the developmental index of the
child was correlated to the first trimester FT4 values of
the mother and not to the TSH levels. One out of every
two women with first trimester FT4 values below the
tenth percentile had a child with a developmental index
more than one SD below the mean. None of these
women were clinically or subclinically hypothyroid.
Because of obvious ethical strictures, direct evidence of
a causal relationship between early maternal hypothy-
roxinemia and mental development can only be obtained
in animal models, such as those previously used to study
the effects of maternal ID on the hippocampus of rat
fetuses (26). At 21 days of gestational age (E21), there is a
delay in the development of radial glial cells of the hip-
pocampus that are involved in neuronal migration. Since
fetal thyroid hormone secretion in rats starts at
E17.5–E18, the delay could have been caused by the inad-
equate synthesis of thyroid hormone by the fetal gland.
Results neither confirmed nor excluded a role of the
maternal hypothyroxinemia before E17.5–E18 — namely,
during an earlier period of development equivalent to the
first half of human pregnancy.
Using BrdU immunocytochemistry, Lucio et al. (27)
and Berbel et al. (28) have shown that neocortical cell
migration is defective in the progeny of severely
hypothyroid dams that were treated with the goitrogen
2-mercapto-1-methylimidazole (methimazole) from
E13 onward. Some of their findings strongly suggest-
ed that early maternal thyroid hormone deficiency
deranges the migratory pattern of cells into the cortex,
either directly by decreasing availability of the hor-
mones to the developing brain or indirectly through
poor placental function caused by maternal hypothy-
roidism. Therefore, it appeared especially interesting to
investigate whether such early migratory defects are
also found in the progeny of hypothyroxinemic dams
that, in contrast to those receiving methimazole, are
not “clinically” hypothyroid.
Methods
Animals and treatments. Wistar rats were housed in tem-
perature-controlled (22–24°C) animal quarters, with
automatic light/dark cycles of 14/10 hours, under veteri-
nary control following European Community guidelines
and approval by the ethics committee of our institutions.
Young adult female rats weighing approximately 200
g were fed a diet with a low-iodine content (LID) for 10
days and given 1% KClO4 as drinking water to lower the
initial content of iodine-containing compounds in the
thyroid gland, after which the 1% KClO4 was with-
drawn. The rats were divided into three groups. The
LID-plus-KI group received LID containing KI to
ensure a normal iodine intake (approximately10 µg of
iodine per day); the LID-1 group was fed LID alone; and
the LID-2 group was fed LID containing 0.005% KClO4,
added to further decrease thyroid uptake of the small
amounts of iodine contained in the LID itself and in
the supplements added throughout pregnancy and lac-
tation to prevent nutritional deficiencies other than ID.
The LID and the supplements were prepared as
described (26). A fourth (normal) group was included
that was fed a stock diet for rats (Sandermus from
Sanders, Barcelona, Spain) to asses that LID-plus-KI
dams were not nutritionally deficient.
After 3 months, blood (approximately 0.5 ml) was
obtained under slight ether anesthesia from the jugular
vein to determine T4 and T3. The plasma was spun off
and kept at –20°C. The rats were mated with normal
males. Vaginal smears and microscopic visualization of
spermatozoa confirmed the day of mating (E0). Each
group of animals was subdivided into two subgroups
depending on when they were injected intraperitoneal-
ly for 3 days with BrdU (20 mg/kg per day in physiolog-
ical saline; Boehringer Mannheim España, Barcelona,
Spain), either at E14, E15, and E16 (E14–E16 subgroup)
or at E17, E18, and E19 (E17–E19 subgroup).
Four dams from each group were killed at E21 and the
weight and number of viable fetuses was recorded. The
pups born to the other dams from each group were
equaled to eight pups per dam at 2–3 days of postnatal
age (P2–P3, with P0 being the day of birth). The different
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feeding regimens were continued after weaning, and at
P40 the pups were weighed, anesthetized, bled, and per-
fused with 50 ml of saline followed by 200 ml of 4%
paraformaldehyde and 0.1 M sucrose in 10 mM PB (pH
7.3–7.4) containing 0.002% CaCl2. Brains were carefully
dissected out and postfixed by immersion in perfusion
solution at room temperature for 4 hours and then
stored at 4°C in PB containing 0.1 M sucrose.
Immunohistochemistry. Parallel series of coronal sec-
tions of 100 µm, cut with a Vibratome and containing
the primary somatosensory cortex (S1, taken at –2.0 to
–4.0 mm from bregma) and the mediocaudal portion
of the hippocampal formation (at –3.8 to –4.3 mm
from bregma), were collected in PBS. One series was
processed for BrdU immunocytochemistry, and an
adjacent series was stained with cresyl violet (Sigma-
Aldrich, St. Louis, Missouri, USA). For BrdU immuno-
cytochemistry, we followed the procedure of Lucio et
al. (27), using BrdU mouse Ab (Amersham Pharmacia
Biotech Ltd., Little Chalfont, Buckinghamshire, UK),
biotinylated horse anti-mouse Ab, an ABC kit (both
from Vector, Burlingame, Cali-
fornia, USA), and 3,3′-diamino-
benzidine (DAB, Sigma-Aldrich).
A second series was incubated
only with anti–mature neurons
neuronal nuclei (NeuN) mouse
Ab (1:100, Chemicon Interna-
tional Inc., Temecula, California,
USA), biotinylated horse anti-
mouse Ab, ABC, and DAB. A
third series was double immuno-
stained, beginning with incuba-
tion with mouse anti-BrdU Ab
and biotinylated horse anti-
mouse Ab, ABC, and DAB inten-
sified with 0.4% ammonium
nickel sulfate (29) and continued
with incubation with a marker
for oligodendrocytes, using
anti–2′,3′-cyclic nucleotide 3′-
phosphodiesterase (CNP) mouse
Ab (1:100, Chemicon) followed
by biotinylated horse anti-mouse
Ab, ABC, and DAB.
Series from the eight sub-
groups were processed in paral-
lel. Immunostained sections
were mounted on gelatinized
slides, air dried for 24 hours,
dehydrated in ethanol, cleared in
xylol, and coverslipped.
Quantification of BrdU-labeled
cells. We plotted only BrdU-
labeled cells that showed intense-
ly and homogeneously labeled
nuclei or diffusely labeled nuclei
of lesser intensity but with
clumped chromatin. These cells
have entered the last S phase of their cell cycle during
uptake of the injected BrdU and correspond to types 1
and 2, respectively, of Takahashi et al. (30).
For quantitative analysis, we studied five LID-1 pups
(three of the E14–E16 and two of the E17–E19 sub-
groups), six LID-2 pups (three of the E14–E16 and
three of the E17–E19 subgroups), seven LID-plus-KI
pups (four of the E14–E16 and three of the E17–E19
subgroups), and six normal pups (three of the
E14–E16 and three of the E17–E19 subgroups). Pups
were taken from two to three litters per subgroup, with
the exception of a single litter for the E17–E19 LID-1
dams. Both in S1 and in hippocampus, BrdU-labeled
cells were counted in a total of 9–12 probes per exper-
imental subgroup; the mean values corresponding to
each pup were later used for statistical evaluation of
the results. In S1, probes represented by templates gen-
erated by the computer system (500–600 µm wide;
mean, 550 µm wide) (Figure 1g) were placed over the
posteromedial barrel subfield (PMBSF or barrel cor-
tex) and spanned from layer I to the subcortical white
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Figure 1
Photomicrographs of coronal sections of primary somatosensory cortex (a–h) and hip-
pocampus (i–l) showing BrdU-labeled cells in normal, LID-plus-KI, LID-1, and LID-2 pups at
P40. BrdU labeling after E14–E16 (a–d) and E17–E19 (e–l) injections shows that both in the
neocortex (a–h) and in the hippocampus (i–l), the radial distribution of BrdU-labeled cells is
more widespread in LID-1 and LID-2 pups than in normal and LID-plus-KI pups. Note the
increased number of heterotopic BrdU-labeled cells in the white matter of the somatosen-
sory cortex (c and d) and in the strata oriens and alveus of CA1 of the progeny of LID-1 and
LID-2 dams (k and l) as compared with the progeny of normal and LID-plus-KI dams (a and
b and i and j, respectively). Horizontal lines indicate the borders between layers. Dashed lines
indicate borders in g and h, since they are blurred in cresyl violet–stained adjacent sections.
Rectangles in g and k show two examples of probes. In each probe, BrdU-labeled cells were
plotted, and the relative frequency per layer was calculated. Borders between layers were
established by superposing adjacent cresyl violet–stained sections. Strata pyramidale, radia-
tum, and moleculare are indicated. Magnification for a–d is 30×; 17× for e–h; and 36× for
i–l. wm, white matter; or, stratum oriens; al, stratum alveus; py, stratum pyramidale; ra, stra-
tum radiatum; mo, stratum moleculare; II–IV, layers II through IV; V–VI, layers V through VI.
matter. In the hippocampus, probes (300–400 µm
wide; mean, 350 µm wide) (Figure 1k) were placed over
the CA1 and CA3 areas and spanned from strata oriens
to moleculare (in CA1, they also included the alveus).
In all cases, the borders between layers and strata were
placed at the same relative depth, as measured from
adjacent cresyl violet–stained sections. For each sub-
group, the relative frequencies of labeled cells in each
layer were averaged across probes and animals.
Determination of serum T3 and T4. Both concentrations
were determined by very sensitive and highly specific
radioimmunoassays (31). The small amounts of avail-
able serum precluded the determination of TSH levels.
Statistical analysis. For body weights, numbers of fetus-
es per litter, litter weights, and concentrations of circu-
lating iodothyronines, we used one-way ANOVA and
the protected least-significant difference test for mul-
tiple comparisons, after validation of the homogeneity
of variances by the Bartlett-Box F test, using the SPSS
statistical package (SPSS Inc., Chicago, Illinois, USA).
Plots and counts of BrdU-labeled cells were obtained
using the Neurograph system (Microptic, Barcelona,
Spain). The Systat statistical software (Systat Inc.,
Evanston, Illinois, USA) was used for two-way ANOVAs
of cell density, the factors being layers in various brain
areas and experimental groups. Significant layer-group
interactions (P < 0.001) were found in the cortex and in
hippocampal CA1 and CA3 both for the E14–E16 and
E17–E19 subgroups. One-way ANOVAs of cell densities
were then used to identify layers affected by the exper-
imental condition, followed by Tukey’s test to identify
significant differences between means. P = 0.05 was
considered significant in all comparisons.
Results
Table 1 summarizes the effects of the different diets on
T4 and T3 just before mating. Results confirm previ-
ous ones in LID-1 and LID-2 dams (26, 32–34). T4 val-
ues in the LID-1 dams were well below normal (<10% of
the values of LID-plus-KI dams), and T3 values
remained normal. In LID-2 dams, however, T3 values
decreased, though much less markedly than T4.
Despite the decrease in T3 values, the reproductive per-
formance of these animals was normal, as was the
postnatal growth of the pups at P40.
In normal and LID-plus-KI pups, the radial distribu-
tion of BrdU-labeled cells in S1 was consistent with
that described previously by Bayer and Altman (35),
showing the normal “inside-out” gradient model of
radial migration. In the E14–E16 subgroups of both
LID-1 and LID-2 progeny, BrdU-labeled cells were
observed in deep layers, whereas in the E17–E19 sub-
groups, they were in more superficial layers. These
findings indicated that most of the cortical cells of the
LID-1 and LID-2 pups also followed a normal “inside-
out” distribution. Despite this, the distribution of
BrdU-labeled nuclei was more widespread in LID-1 and
LID-2 pups than in normal and LID-plus-KI progeny,
showing an abnormal number of heterotopic BrdU-
labeled cells — that is, cells found in layers different
from those corresponding to their birth date and at
aberrant locations, such as the subcortical white mat-
ter (Figure 1, a–d). As a general feature, the percentage
of BrdU-labeled cells in LID-1 and LID-2 pups decreas-
es in superficial layers and increases in deeper ones as
compared with normal pups (Figure 1, e–h). Thus, in
LID-1 and LID-2 progeny, the proportion of BrdU-
labeled cells labeled at E14–E16 decreased in layer VI
and increased in the subcortical white matter (see P val-
ues in Figure 2, a and b), whereas the proportion of
BrdU-labeled cells at E17–E19 decreased in layers II–III
and IV and increased in layers V and VI and in white
matter. In LID-2 pups, heterotopic BrdU-labeled cells
in white matter were observed after both E14–E16 and
E17–E19 injections (8.0% ± 1.6% and 5.3% ± 1.4%,
respectively, as compared with <0.6% for the normal
and LID-plus-KI subgroups). In LID-1 pups, BrdU-
labeled cells were mostly observed after E14–E16 injec-
tions (7.2% ± 0.6% at E14–E16 and 1.4% ± 0.4% at
E17–E19 as compared with <0.6% for the normal and
LID-plus-KI subgroups).
The radial distributions of BrdU-labeled cells in CA1
and CA3 of both subgroups of normal and LID-plus-
KI progeny were similar and consistent with previous
descriptions for normal rats (36). In contrast, their dis-
tribution was more widespread in LID-1 and LID-2
pups, both in CA1 and CA3, showing an abnormal
number of heterotopic BrdU-labeled cells (Figure 1,
i–l). As a general feature, both at E14–E16 and at
E17–E19, the percentage of BrdU-labeled cells in CA1
of LID-1 and LID-2 pups decreases with respect to nor-
mal and LID-plus-KI rats in the pyramidal layer (see P
values in Figure 2, c–f) and increases in strata alveus
and oriens. In CA3 of both subgroups, the percentage
of BrdU-labeled cells also decreases with respect to nor-
mal and LID-plus-KI rats in the pyramidal layer, but
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Table 1
Circulating thyroid hormones in dams from the experimental groups, their reproductive performance, and the body weights of their P40 progeny
Serum T4 Serum T3 Number of fetuses Fetal weight Weight of litter Weight at P40
(ng/ml) (ng/ml) per litter (g) (g) (g)
Normal 35.9 ± 6.3 0.73 ± 0.02 11.0 ± 0.9 5.2 ± 0.1 51.5 ± 2.3 131 ± 4
LID-plus-KI 26.1 ± 2.7 0.69 ± 0.06 10.0 ± 1.4 5.1 ± 0.1 50.9 ± 6.3 132 ± 4
LID-1 <2.5A 0.65 ± 0.15 9.8 ± 0.9 5.2 ± 0.1 50.6 ± 5.3 130 ± 3
LID-2 <2.5A 0.37 ± 0.06A 9.8 ± 1.6 5.2 ± 0.0 46.6 ± 2.3 129 ± 4
Results are shown as mean values ± SEM. AThe difference was statistically significant as compared with the LID-plus-KI group.
increases in the outer plexiform layer. No BrdU-labeled
cells were found in the alveus of any of the subgroups
of normal and LID-plus-KI pups.
In addition to an aberrant distribution of BrdU-
labeled cells, there were changes in the cytoarchitecture
of the barrel cortex and of the hippocampus (cresyl vio-
let–stained sections) in LID-1 and LID-2 pups. The bar-
rel cortex of LID-plus-KI pups (Figure 3a) was similar
to that of normal pups (not shown), and the major
cytoarchitectonic features are typical barrels that can
be seen in layer IV, large pyramids in layer V, and easily
distinguishable borders within all layers. In contrast,
these features are less prominent in the progeny of 
LID-1 and LID-2 dams (Figure 3, b and c); barrels are
not clearly defined in layer IV (neurons were more
homogeneously distributed and septae that demarcat-
ed barrels were not seen), pyramids in layer V are small-
er than normal, and the borders between layers II–VI
are blurred. However, no differences were found in the
thickness of the cortex among the four groups (on aver-
age, 1744 ± 42 µm in normal and LID-plus-KI pups ver-
sus 1738 ± 133 in LID-1 and LID-2 pups).
In the hippocampus, as in the barrel cortex, the gross
cytoarchitecture of LID-plus-KI pups (Figure 3, d–f)
was similar to that of normal pups (data not shown).
In CA1, the pyramidal cell layer showed
clear-cut borders with the adjacent stra-
ta. In contrast, both in CA1 and CA3 of
LID-1 and LID-2 progeny, the border of
the pyramidal layer with the strata
oriens was more blurred (Figure 3, g–i).
In addition, the stratum radiatum in
CA1 was 14% thinner than normal (on
average, 268 ± 17 µm in normal and
LID-plus-KI pups versus 231 ± 23 µm in
LID-1 and LID-2 pups).
NeuN immunostaining confirmed
the results found in cresyl violet–stained
sections, where the borders between lay-
ers were blurred (Figure 4, a and b), and
showed an increased number of hetero-
topically located neurons in the subcor-
tical white matter (Figure 4, c and d)
and in hippocampal strata oriens and
alveus (Figure 4, e and f) of LID rats, as
compared with LID-plus-KI and normal
rats. CNP-positive oligodendrocytes
showed a light-brown–stained cell body
and processes (Figure 4g). The cell body
of CNP-positive oligodendrocytes (be-
tween 5–8 µm in diameter) was smaller
than that of nuclei of most of the BrdU-
labeled cells (between 10–15 µm in
diameter). In both the E14–E16 and the
E17–E19 subgroups of LID rats and
their controls, some cells that were both
BrdU-labeled and CNP-positive were
occasionally seen, but in very small
numbers. These double-labeled cells
showed a partial BrdU labeling that was limited to
the clumped chromatin corresponding to the type 3
cells described by Takahashi et al. (30) and were not
counted by us. No CNP-positive cytoplasm and
processes were seen in close contact with type 1 and
2 BrdU-labeled nuclei.
Discussion
The experimental design. We have shown previously (26,
32–34) that the present experimental design is quite
different from that of models used to induce severe
hypothyroidism in dams and/or pups. The latter usu-
ally involve surgical thyroidectomy of the dams or their
treatment with goitrogens, such as methimazole (26,
31). In contrast with thyroidectomized and with goitro-
gen-treated dams, the present LID-1 and LID-2 dams
could not be distinguished from their controls by phys-
ical appearance, by growth, or by their reproductive
performance. Neither were visible “clinical” signs of
neonatal or juvenile hypothyroidism (poor hair, differ-
ent skull proportions, abnormal locomotion, poor
growth) observed in their progeny. In these different
experimental models, the concentrations of T4 and T3
that we found in embryonic and fetal samples and in
placentas before E18 reflect the pattern of changes
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Figure 2
Histograms showing the percentage of BrdU-labeled cells in various layers of the pri-
mary somatosensory cortex and the CA1 and CA3 regions of the hippocampus.
Results for the progeny of the E14–E16 subgroups of normal, LID-plus-KI, LID-1, and
LID-2 dams are shown in a, c, and e. Results for the E17–E19 subgroups are shown
in b, d, and f. Error bars represent SD across layers from the same group. Single aster-
isk indicates a significant difference between the LID-1 or LID-2 group and their con-
trol group (LID-plus-KI and normal groups); crosshatch indicates a significant dif-
ference between the LID-1 group and the LID-2 group. The F and P values
corresponding to layers for which significant differences were found between groups
are shown in the upper part of each panel. The degrees of freedom were 3, 9 for the
E14–E16 subgroups and 3, 7 for the E17–E19 subgroups. inner plexif., inner plexi-
form stratum; outer plexif., outer plexiform stratum.
observed in the maternal plasma (31, 37, 38). Thus, the
thyroidectomized dams have very low circulating levels
of T4 and T3 up to E21, as do all samples obtained
from the conceptus between E9 and E18 — namely,
E9–E12 embryotrophoblasts, E9–E12 placentas, and
E13–E17 whole embryos. The mean number of fetuses
per litter (6.8 ± 0.3), the mean fetal weight (4.2 ± 0.1 g),
and the mean weight of the litter (26.8 ± 1.0 g) of viable
fetuses at E21 were markedly reduced. In contrast, in
the hypothyroxinemic LID-1 dams, we have found
(32–34, 39) that circulating T4 is very low up to E21, as
are the T4 concentrations in E11 embryotrophoblasts
and in E17 placentas and whole embryos. The corre-
sponding T3 concentrations, however, usually remain
normal (E11) or decrease (E17 placentas and embryos),
but to a much lesser extent than T4. This decrease
occurred also in the present LID-2 dams, despite the
fact that, as indicated above, neither the dams nor the
progeny were “clinically” hypothyroid.
Whether the concentrations of T4 and T3 in the brain
of LID fetuses before E17–E18 follow a different pattern
than suggested by the maternal circulating levels of
both iodothyronines has not been clarified, because of
the lack of sensitivity of available methods. Information
obtained for fetuses of thyroidectomized dams (38)
revealed that the activity of type II 5′-iodothyronine
deiodinase (5′D-II) in the fetal brain was not influ-
enced by maternal thyroidectomy alone and that
both T4 and T3 at E17 were decreased, as expected
from the decreased maternal circulating levels. When
the thyroidectomized dams were given methimazole
and fetal thyroid function was impaired, 5′D-II activ-
ity did not appear to be upregulated by the decrease
in fetal T4 until E19 or later (34, 38, 39). In the fetus-
es of LID dams, an increase in 5′D-II activity was also
not observed until E19 and was insufficient for the
maintenance of normal cerebral T3.
Early effects on the development and organization of S1
and hippocampus. A significant number of heterotopic
cells were found that are abnormally located in the
S1 and in the hippocampus of the progeny of both
LID-1 and LID-2 dams, although neither the pups
nor the dams were hypothyroid. NeuN single stain-
ing shows that the heterotopic cells that were found
in the subcortical white matter of pups from the
E14–E16 subgroups of both LID-1 and LID-2 ani-
mals are mostly neurons. In addition, BrdU-labeled
cells from the E14–E16 and E17–E19 subgroups of
LID pups and their controls are not likely to be
oligodendrocytes: no type 1 or type 2 BrdU-labeled
cells were found that were double-labeled for CNP.
In contrast, the number of type 3 BrdU-labeled cells
that were also CNP-positive was not negligible, espe-
cially in E17–E19 subgroups. These might have been
oligodendrocytes that had undergone successive
mitoses before P40. Our results, therefore, led us to
conclude that maternal hypothyroxinemia clearly
results in an alteration of neuronal migration dur-
ing neocorticogenesis, but the possibility cannot be
excluded that the abnormal migration might also
affect glial cells, especially those oligodendrocytes
that reached the neocortex from the ganglionic emi-
nence through tangential migration (40, 41).
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Figure 3
Photomicrographs of cresyl violet–stained coronal sections
showing the cytoarchitecture of the PMBSF of the primary
somatosensory cortex (a–c) and hippocampal CA1 (d–i) in
LID-plus-KI, LID-1, and LID-2 progeny at P40. In the PMBSF of
LID-plus-KI pups, borders between layers are clear-cut, as
expected in normal animals (horizontal lines in a), whereas in
LID-1 and LID-2 pups they are blurred (horizontal dashed lines
in b and c). In layer IV of LID-plus-KI pups, barrels are normal
and well defined, as indicated by an arrow in a, and demar-
cated by septae (arrowheads). In contrast, barrels in layer IV of
LID-1 and LID-2 pups (b and c) are not seen. Enlargements of
the insets outlined in d–f are shown in g–i. In the hippocam-
pus, the differences between LID-plus-KI pups and both LID-1
and LID-2 pups are not prominent at low magnification (com-
pare d with e and f). However, at a higher magnification, the
border between strata pyramidale and oriens in CA1 of LID-
plus-KI pups is more clear-cut than in LID-1 and LID-2 proge-
ny (compare g with h and i). Note that strata radiatum is thin-
ner in LID-1 and LID-2 pups than in LID-plus-KI pups. The
stratum moleculare is also indicated. Magnification for a–c is
54×; 8× for d–f; and 76× for g–i.
The observed alterations do not correspond merely to
a delay of the normal migratory process, because het-
erotopic cells are found in aberrant destinations (i.e.,
subcortical white matter and stratum alveus of hip-
pocampal CA1), where they are hardly ever found at
any BrdU injection time in the normal animals that we
have studied or in the subcortical white matter of nor-
mal rats injected with BrdU between E12 and E15 (42).
We wish to point out that the aberrant migration of
cortical neurons labeled at E14–E16 into the white
matter clearly identifies a very important alteration in
brain development that is entirely caused by the mater-
nal thyroid hormone deficiency alone. These neurons
incorporated BrdU in the last S phase of their cell cycle,
the latest ones incorporating it at E16, starting migra-
tion from the ventricular zone and reaching the corti-
cal plate before E18 (35). If the onset of the migration
process in the LID fetuses were delayed for 2–3 days, it
would overlap with that of fetal thyroid function, and
the observed abnormalities could no longer be related
to the maternal hypothyroxinemia alone. However, the
systematic finding of labeled cells in aberrant locations
is not explained by such a delay alone. Moreover, when
goitrogen-treated dams were given single pulses of
BrdU at various times between E14 and P0, no differ-
ences were found between the pups from the normal
and hypothyroid dams in the proportion of labeled
cells in S1, whatever the timing of the BrdU injections
(28). After labeling at E19, the number of labeled cells
was equally very low in both groups of pups. The find-
ings reported here support the above conclusion that
the migratory process we have studied in the E14–E16
subgroups takes place before the onset of fetal thyroid
hormone secretion at E17.5–E18 and can, therefore,
only be related to alterations of maternal, but not of
fetal, thyroid function.
This present conclusion is strongly supported by the
preliminary results with a different experimental
model (43). Rat dams receiving methimazole for only 3
days (E12, E13, and E14) were subdivided into E14–E16
and E17–E19 subgroups. Abnormalities in cell migra-
tion similar to those described here were found in the
cortex and hippocampus of the progeny of both sub-
groups, despite rapid normalization of the maternal
thyroid status after withdrawal of methimazole on E15.
The observed abnormalities were prevented by the infu-
sion of T4 into the methimazole-treated dams.
The amount of BrdU incorporated into the cell, the
time of injection, and the clearing time of BrdU (6–8
hours on average) might affect the number of labeled
cells. However, the present findings are not likely to be
caused merely by small differences between experi-
mental groups in the injection time, considering that
different litters were used for each group at each injec-
tion period in order to minimize this possibility.
The mechanisms underlying abnormal migration in
LID pups are not known and need further study. In this
respect, it is interesting that a delayed maturation of
the hippocampal radial glia has been found in LID
fetuses at E21 (26). This delay in the maturation of
radial glia might also occur in the neocortex and might
reflect cellular and molecular alterations that would
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Figure 4
Photomicrographs of NeuN-immunostained coronal sections of the primary somatosensory cortex (a–d) and hippocampal CA1 (e and f) in
LID-plus-KI (a, c, and e) and LID-1 (b, d, and f) progeny at P40. In the neocortex of LID-1 pups, borders between layers are more blurred (hor-
izontal dashed lines in b) than in LID-plus-KI rats (horizontal lines in a). The number of NeuN-labeled neurons increases both in subcortical
white matter and in strata oriens and alveus of hippocampal CA1 of LID-1 rats (d and f, respectively) as compared with LID-plus-KI rats (c and
e). In g, CNP-positive oligodendrocytes (arrowheads) and BrdU-labeled nuclei (arrows) are shown in layer V of a LID-1 rat from an E14–E16
subgroup. Note that CNP-positive oligodendrocytes are BrdU negative.
interfere with normal cell migration at earlier stages of
histogenesis, affecting not only their radial but also
their tangential migration. In addition to abnormal
migration, histogenetic abnormalities might occur in
LID rats, affecting neuronal generation and survival. In
particular, a survival of some neurons generated at
E14–E16 — namely, those transiently destined for the
subplate — cannot be excluded. Thus, in LID rats, het-
erotopic neurons might result not only from an altered
migration but also from an abnormal stabilization of
neurons that would normally be eliminated. Whichever
the case, the migration pattern in fetuses of the LID-1
and LID-2 groups is different from normal.
With experimental models involving prolonged
goitrogen treatment of the dams, it is not possible to
clarify whether the resulting changes in brain develop-
ment of their progeny are caused directly by a decreased
availability of thyroid hormones to the developing
brain or indirectly through hypothyroidism of the pla-
centa, which could affect the entire development of the
fetus. This second possibility is quite unlikely in the
case of the present LID-1 and LID-2 dams, because
although they were severely hypothyroxinemic, their
placental function was spared, as shown by their nor-
mal reproductive competence. Another epigenetic fac-
tor affecting CNS development, such as malnutrition,
can also be excluded: results from the LID-plus-KI
group could be superimposed on those from the nor-
mal animals, confirming that the present supplement-
ed LID was nutritionally adequate (26). The normal lit-
ter size, fetal weights, and postnatal growth of the
progeny from the LID-1 and LID-2 dams also shows
that malnutrition was not a causal factor for the abnor-
malities in brain development described here.
The finding that the neuronal migration pattern and
cytoarchitectonic organization are abnormal in the
LID-1 pups, born from mothers with markedly reduced
circulating T4 but with normal T3, also supports pre-
vious conclusions that availability to the developing
brain of maternal T4 is of greater importance than that
of T3, because T3 in the fetal brain is almost entirely
dependent on its local generation from T4 (4, 44) and
not on the uptake of circulating T3. The same occurs
in human ID, in which the cerebral damage is correlat-
ed with the maternal hypothyroxinemia, not with
maternal T3 or TSH (17, 22). Present results do not
exclude that continuing maternal hypothyroxinemia
later in pregnancy and/or persisting postnatal hypothy-
roxinemia of the progeny might result in even more
CNS damage and the derangement of a greater spec-
trum of functional abnormalities (23). It might, for
instance, also affect migratory patterns of cells under-
going continuous neurogenesis, such as that occurring
in the hippocampus of mammals including rats (45)
and humans (46), and the functional properties of
newly generated hippocampal cells (47), which might
explain CNS deficits not related to early pregnancy.
The abnormalities in neuronal migration and the
subtle changes in cytoarchitectonic organization found
in the progeny of both LID-1 and LID-2 dams indicate
that the normal process of brain maturation and, con-
sequently, the establishment of normal brain functions
are likely to be impaired. In this respect, it is interesting
that the progeny from LID dams show increased
audiogenic seizure susceptibility (37, 48). The observed
reduction in the thickness of the stratum radiatum in
LID-1 and LID-2 pups suggests a reduction in the
length of apical dendrites of pyramidal neurons, such
as has been reported in granule and pyramidal cells of
the hippocampus of goitrogen-treated hypothyroid rat
pups (49). It is very likely that abnormal migration also
results in aberrant circuits in the neocortex and the
hippocampus in the progeny of LID-1 and LID-2 dams,
considering that changes in GABAergic (50) and in cal-
losal (27, 51) and thalamocortical connections (29)
have been found in goitrogen-treated rat pups, in
which altered migration also occurs and barrel forma-
tion is deranged. Identification of detectable function-
al deficits caused in the rat by the anatomical alter-
ations described here will require further studies.
Recent studies by others (52) have also focused on the
importance of maternal thyroid hormone insufficien-
cy early in pregnancy. Alterations of the expression of
several cerebral genes were found in the fetuses of thy-
roidectomized or goitrogen-treated dams, but they did
not persist and returned to normal within a few days;
they were also found in rats that started receiving
goitrogens as adults. The significance of these obser-
vations for brain development are not well understood,
since the reported genes are not known to be clearly
involved in any developmental processes.
The present study is, to our knowledge, the first to
show an effect of early maternal hypothyroxinemia on
the histogenesis and cytoarchitecture of the cerebral
cortex of the fetus, whether or not circulating T3
decreases, and without clinical manifestations of
hypothyroidism. Although we have not performed
direct experiments to define the developmental period
during which these effects might be avoided by correc-
tion of the maternal hypothyroxinemia with iodine or
T4, it appears reasonable to assume that the alterations
would soon become irreversible. To our knowledge,
cells that are found in aberrant locations do not later
reach their normal destinations. The intrinsic and
extrinsic factors (i.e., radial glial guidance, extra- and
intracellular signaling, etc.) that allow cortical neurob-
lasts to complete their process of migration change
very rapidly. In particular, radial glia differentiate to
cortical astrocytes, extracellular signaling molecules are
expressed transiently, and the complexity of neuropile
increases as neuroblasts differentiate and the process
of synaptogenesis begins around birth in the rat and by
the twenty-fourth week of gestation in humans (53). All
these changes associated with cortical development
and maturation begin after neurogenesis and strongly
suggest that cells trapped in aberrant locations could
not later reach their normal destinations, even if an
appropriate treatment with iodine or T4 were then
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instituted. The findings summarized above from the
experiment in which dams were treated with methima-
zole for only 3 days also support this conclusion (38).
Possible implications for maternal hypothyroxinemia in
humans. Present results may help our understanding
of epidemiological findings in man. In humans, het-
erotopic cells have been described in the neocortex of
therapeutically aborted fetuses from an ID region
(54). These heterotopic cells can also be observed in
human neurological disorders, such as epilepsy (55,
56). There are important differences in the timing of
neocorticogenesis between humans and rats with
respect to the stages of pregnancy. In humans, neo-
cortical development occurs between the sixth and
twenty-fourth week of gestation, with the cortical
plate beginning to form by E54 (by the eighth week of
gestation). The bulk of cortical cell migration occurs
between the eighth and twenty-fourth week of gesta-
tion — namely, before the end of the second trimester
(53) and mostly before onset of fetal thyroid hormone
secretion, at midgestation. In the rat, neocorticogen-
esis begins comparatively later (by E13) and is not
over until a few days after birth, with the major part
of the process occurring between E14 and E19, near-
er to birth than in humans but again before onset of
fetal thyroid function (at E17.5–E18). Thus, despite
the differences in timing of neurodevelopmental
events between both species when birth is taken into
account, similarities may be established when onset
of fetal thyroid secretion is considered.
Two main waves of cell migration occur in the
human neocortex that take place during the first half
of gestation, with peaks at 11 and 14 weeks of gesta-
tional, or postmenstrual, age (equivalent to 9 and 12
weeks of postconceptional, or fetal, age, respectively)
(57), roughly corresponding to the fetal ages studied
here in rats. Our results in rats therefore suggest that
these migrations could also be deranged in the proge-
ny of mothers who have been hypothyroxinemic dur-
ing the first half of pregnancy, a possibility that we can-
not ethically confirm or disprove. The subtle changes
in migration and cytoarchitecture described here may
well be the underlying cause of the decreased mental
development described in children born in areas of
mild and moderate ID (19), whose mothers are
hypothyroxinemic without being hypothyroid. They
may also be related to the mental deficits of children
born from mothers whose hypothyroxinemia early in
pregnancy might be due to other causes (2, 4, 5, 7).
Although the mental impairment attributed to early
maternal hypothyroxinemia is usually not as severe as
that of children with CH who are deprived of early thy-
roid hormone treatment, the number of children at
risk for neurodevelopmental deficits related to early
maternal hypothyroxinemia is 150–200 times greater
than that of newborns with CH.
Maternal hypothyroxinemia is not detected in most
pregnant women early in pregnancy, because it does not
necessarily result in clinical or even “subclinical”
hypothyroidism. The mother herself may synthesize and
secrete enough T4 and T3 to meet her own needs, but
the amount of T4 reaching the fetus might not be suffi-
cient for its normal neurodevelopment. The most fre-
quent cause of maternal hypothyroxinemia worldwide is
ID, even if mild or moderate; it is not only still common
among European pregnant women (25) but is also
beginning to be of concern in the United States (58).
However, ID is not necessarily the only cause of
maternal hypothyroxinemia occurring without an
increase in TSH above normal values. The present
results strongly support our previous conclusion (2)
regarding the need to establish mass screening pro-
grams of pregnant women early in gestation. For the
sake of the unborn child, these programs should be
based primarily on first trimester parameters related to
circulating T4 and not only on the detection of thyroid
antibody positivity and increased serum TSH, as previ-
ously proposed for the sake of the mother (59).
In conclusion, present results suggest that, during
development, thyroid hormones have selective effects
on processes that take place early in fetal development,
such as migration during histogenesis and the cytoar-
chitectural organization of the cerebral cortex. Any sit-
uation resulting in a decreased availability of T4 to the
fetal brain is potentially adverse for neurodevelopment.
Maternal hypothyroxinemia appears to be a much
more frequent cause of deficits in the progeny than
CH, for which we have successful neonatal thyroid
screening programs.
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